ArticleFrontiers in pharmacology2022

Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction.

Yuwei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.